Physician profile
Kaci Thomas Fields
NPI 1659035541
$1,575.92
in general payments reported to CMS, 2019-2025
18 companies · $604 in 2025
The $604 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $355 · 2023: $253 · 2024: $364 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.87 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $337.98 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $205.15 | 2022-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $158.38 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $145.00 | 2022-2024 | |
| Exeltis, USA INC. | $140.89 | 2022-2025 | Twirla, Slynd |
| Mayne Pharma Commercial LLC | $121.58 | 2023-2025 | |
| Sage Therapeutics, LLC | $100.78 | 2022-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $73.65 | 2025 | Myfembree |
| Shield Therapeutics INC | $46.12 | 2025 | |
| Minerva Surgical, INC | $36.95 | 2023 | |
| Pfizer INC. | $36.19 | 2022-2025 | |
| Innovation Technologies INC | $34.18 | 2022 | |
| Merck Sharp & Dohme LLC | $32.20 | 2022-2025 | Gardasil 9 |
| Coopersurgical, INC. | $25.48 | 2025 | Paragard T 380a |
| Pharmacosmos Therapeutics INC. | $25.45 | 2025 | Monoferric |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.23 | 2022 | |
| Millicent US INC | $17.50 | 2025 | Femlyv |
| Mycovia Pharmaceuticals, INC. | $16.21 | 2023 | Vivjoa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaci Thomas Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.